Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative Pathogens

INTRODUCTION: Antibiotic-resistant Gram-negative bacteria have been associated with substantial morbidity and mortality and have limited treatment options available. Omadacycline (OMC) is an aminomethylcycline antibiotic that has been shown to exhibit broad in vitro activity against antibiotic-resis...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrisette, Taylor, Alosaimy, Sara, Lagnf, Abdalhamid M., Frens, Jeremy J., Webb, Andrew J., Veve, Michael P., Stevens, Ryan, Bouchard, Jeannette, Gore, Tristan W., Ansari, Iman, Rybak, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334473/
https://www.ncbi.nlm.nih.gov/pubmed/35567718
http://dx.doi.org/10.1007/s40121-022-00645-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334473/
https://www.ncbi.nlm.nih.gov/pubmed/35567718
http://dx.doi.org/10.1007/s40121-022-00645-5

Ejemplares similares